Blood Cancer Clinical Trial
Observation of Myelodysplastic Syndromes
The National Myelodysplastic Syndromes (MDS) Study
The purpose of The National MDS Study is to build a resource that scientists can use to learn more about a group of rare bone marrow diseases called myelodysplastic syndromes (MDS). This resource will enable scientists to conduct research on how to improve the ways MDS is diagnosed and treated. The study will also help scientists, patients, and their families better understand what to expect when a patient is diagnosed with MDS. For more information, visit TheNationalMDSStudy.net.
Physician and Research Staff Educational Material
This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.
- Physician Fact Sheet: schema, eligibility criteria, and treatment details
- Pocket Reference Card: trial schema, study objectives, and eligibility requirements on a pocket-sized card for easy reference when consulting with patients in the office or on rounds
- Site Process Summary: schema, objectives, and details about how your site can participate
Information and Assistance from the National Cancer Institute
- Locations and other information
- Trained information specialists at the NCI are available to answer cancer-related questions from patients, family members or friends, health care providers, and researchers. Visit the NCI’s Cancer Information Service webpage for contact instructions, including telephone, live chat, email, and mail.
ClinicalTrials.gov ID: NCT02775383
Return to Home Page | Review Other Active Trials